Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsEventsSponsored PodcastsSponsored VideosWebcastsWhitepaperseBooks
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Finlay Aitcheson, Product Development, Syft Technologies

Advertisement

Articles by Finlay Aitcheson, Product Development, Syft Technologies

Nitrosamine Detection in Pharmaceuticals: A Faster, Greener, and More Effective Approach

ByFinlay Aitcheson, Product Development, Syft Technologies
March 1st 2025
Advertisement

Latest Updated Articles

  • Nitrosamine Detection in Pharmaceuticals: A Faster, Greener, and More Effective Approach
    Nitrosamine Detection in Pharmaceuticals: A Faster, Greener, and More Effective Approach

    March 1st 2025



Advertisement
Advertisement

Trending on PharmExec

1

Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro

2

Hims & Hers Partners with Eli Lilly to Sell Obesity Medicines

3

What Does a Positive Reading for Leronlimab Mean for How the Industry Thinks About Repurposing Old Biologics Into Oncology?

4

The US Drug-Pricing Reset: Competing on Net Value

5

The Promise of Microgravity for R&D and Manufacturing

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us